SCHEMBL19976730

SCHEMBL19976730

CC(C)(C)N/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.41
JAK2 O60674 2/20 0.39
MAPK10 P53779 6/20 0.39
MAPK8 P45983 4/20 0.39
GSK3B P49841 4/20 0.37
PLK4 O00444 1/20 0.37
MAPK13 O15264 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
CDK1 P06493 1/20 0.37
PIM1 P11309 1/20 0.37
CDK2 P24941 1/20 0.37
MARK3 P27448 1/20 0.37
FLT4 P35916 1/20 0.37
MAPK9 P45984 1/20 0.37
CDK8 P49336 1/20 0.37
CLK2 P49760 1/20 0.37
MAPK12 P53778 1/20 0.37
CDK5 Q00535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976765 0.89 NTRK1 (0.41) HDAC6JAK2MAPK8GSK3BPLK4
SCHEMBL19976757 0.87 HDAC6 (0.39) HDAC6MAPK10MAPK8GSK3BPLK4
SCHEMBL19976801 0.87 TRPA1 (0.37) HDAC6JAK2MAPK8GSK3BPLK4
SCHEMBL19976726 0.87 ABL1 (0.41) HDAC6JAK2MAPK10MAPK8GSK3B
SCHEMBL19976736 0.87 MAP2K4 (0.44) HDAC6JAK2MAPK10MAPK8GSK3B
SCHEMBL19976725 0.87 GSK3B (0.52) HDAC6MAPK10MAPK8GSK3BDYRK1A
SCHEMBL19976929 0.86 RIPK1 (0.37) HDAC6JAK2DYRK1AAURKBMAPK1
SCHEMBL19976804 0.84 TRPA1 (0.37) HDAC6JAK2MAPK8GSK3BPLK4
SCHEMBL19976846 0.83 KDM4E (0.42) HDAC6MAPK10MAPK8GSK3BPLK4
SCHEMBL19976802 0.82 KDR (0.36) JAK2CDK2FLT4DYRK1AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed